Patients' Guidance With Onco-Coaching and CANKADO on Systemic Chemotherapy for Metastatic Colorectal Cancer
POSCA
1 other identifier
observational
40
1 country
2
Brief Summary
This is a prospective, single arm, non-interventional project to evaluate the benefit/influence of individualized patient education and guidance with a web-based e-Health platform called CANKADO on patient reported outcomes (PRO) for patients with metastatic colorectal cancer. The focus will be on patient reported outcomes (PRO), distress, Quality of Life (QoL), Global Health Status, complaints and therapy relevant decisions. All patients will be medically treated according to the standards. The experimental arm will include 40 patients. Those patients will receive one initial coaching before start of therapy. Further appointments for coaching will be scheduled depending on individual patient's need. During treatment period the patient is encouraged of joining therapy actively documenting his state of health and occurring health complaints via CANKADO to give the physician a better overview on the process of patient's health behaviour and preparing him for the next doctor-patient consultation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2017
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 11, 2017
CompletedFirst Submitted
Initial submission to the registry
May 6, 2020
CompletedFirst Posted
Study publicly available on registry
May 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2021
CompletedJuly 12, 2022
July 1, 2022
4.4 years
May 6, 2020
July 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Development of patients' Distress
Evaluated using the Screening Tool for Measuring Distress described by the Practice Guidelines in Oncology - v. 1.2005 by the National Comprehensive Cancer Network
6 months
Secondary Outcomes (2)
Patient's Quality of Life (QoL)
6 months
Patient's global health status
6 months
Eligibility Criteria
Adult patients with metastatic colorectal cancer in first line treatment treated in "Gemeinschaftspraxis für Hämatologie und Onkologie Langen" or "Hämato-Onkologische Schwerpunktpraxis am Klinikum Aschaffenburg"
You may qualify if:
- Minumum age of 18 years
- Patient with metastatic colorectal cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cankado GmbHlead
Study Sites (2)
Hämato-onkologischer Studienkreis am Klinikum Aschaffenburg
Aschaffenburg, 63739, Germany
Gemeinschaftspraxis für Hämatologie und Onkologie
Langen, 63225, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Timo Schinköthe, PhD
Cankado GmbH
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2020
First Posted
May 19, 2020
Study Start
July 11, 2017
Primary Completion
December 20, 2021
Study Completion
December 20, 2021
Last Updated
July 12, 2022
Record last verified: 2022-07